How much did Adaptyv Bio raise?

Adaptyv Bio raised €34.35M at Series A, announced 27 August 2026.

Who founded Adaptyv Bio?

Julian Englert is Co-founder of Adaptyv Bio.

What does Adaptyv Bio do?

Adaptyv Bio operates in HealthTech and is based in Switzerland.

FundedStartupsDaily / HealthTech / Adaptyv Bio

Adaptyv Bio raises €34.35M

Adaptyv Bio announced a Series A round of €34.35M on 27 August 2026. The company operates in HealthTech and is based in Switzerland. It was founded by Julian Englert, Co-founder. Announced 40 days ago.

Raised

€34.35M

Stage

Series A

Industry

HealthTech

Country

Switzerland

Founder

Julian Englert

Co-founder, Adaptyv Bio

LinkedIn profile adaptyvbio.com

Outreach angles

-Co-founder Julian Englert is building Adaptyv's automated, AI-native lab for protein design alongside co-founder Daniel Nakhaee-Zadeh Gutierrez.
-Adaptyv is a Y Combinator alum, with YC doubling down as an investor in this Series A alongside Highland Europe, Ace Ventures, and ByFounders.
-The €34.35M Series A will fund Adaptyv's build-out of a fully automated cloud lab for agentic biology and protein engineering.